https://www.selleckchem.com/products/h3b-6527.html
he effectiveness and safety profile of fingolimod in real-world setting in the Middle East and North African (MENA) region. Pregnancy among patients with congenital myasthenic syndrome (CMS) is a rare occurrence. Since most of the patients with CMS reach adulthood, questions regarding clinical outcome with pregnancy arise. We describe a 38-year-old Portuguese female who presented in the second trimester of pregnancy with proximal fluctuating limb-girdle weakness, hyperlordosis, waddling gait, dysphagia, dysphonia and ptosis, with no op
Like
Comment
Share
